IsoTis S.A.
Consolidated Statements of Operations-Unaudited
US Dollars
Three Months Ended Nine Months Ended
30-Sep-06 30-Sep-05 30-Sep-06 30-Sep-05
- - - -
Revenues
Product
sales US$ 10,161,972 US$ 8,146,900 US$ 30,729,113 US$ 23,450,049
Other revenue - - 35,816 38,825
- - - -
Total revenues 10,161,972 8,146,900 30,764,929 23,488,874
- - - -
Operating expenses
Costs of sales 3,630,693 3,261,653 11,304,813 9,183,912
Research and
development 1,983,751 1,735,114 5,591,768 4,171,131
Marketing and
selling 4,667,770 3,315,938 13,200,975 9,310,025
General and
administrative 2,978,011 2,152,586 8,445,734 7,938,321
- - - -
Total operating
expenses 13,260,225 10,465,291 38,543,290 30,603,389
- - - -
Loss from
operations (3,098,253) (2,318,391) (7,778,361) (7,114,515)
Interest income 161,784 131,427 440,021 385,975
Interest expense (75,735) (31,807) (132,219) (156,555)
Foreign exchange
gain/(loss) 941,506 301,706 (4,568,038) 8,625,190
Other 146,019 431,548 142,100 663,351
- - - -
Net (loss)
income before
taxes (1,924,679) (1,485,517) (11,896,497) 2,403,446
Provision for
income taxes - - - -
- - - -
Net (loss)
income US$ (1,924,679)US$ (1,485,517)US$ (11,896,497) US$ 2,403,446
- - - -
Basic and diluted
net (loss) income per
share US$ (0.03) US$ (0.02) US$ (0.17) US$ 0.03
- - - -
Weighted average
common shares
outstanding
Basic 70,940,713 70,681,023 70,918,356 70,349,586
Diluted 70,940,713 70,681,023 70,918,356 72,407,899
IsoTis S.A.
Consolidated Balance Sheets
------------------ -----------------
September 30, 2006 December 31, 2005
------------------ -----------------
Assets (Unaudited) (Audited)
Current assets:
Cash and cash equivalents US$ 16,909,442 US$ 15,714,442
Restricted cash 1,634,357 2,184,063
Trade receivables, net 7,548,822 6,306,518
Inventories 12,921,460 10,020,906
Unbilled receivables 74,069 295,115
Value added tax receivable 120,944 95,505
Prepaid expenses and other current assets 979,227 761,355
------------------ -----------------
Total current assets 40,188,321 35,377,904
Non-current assets:
Restricted cash 1,500,000 2,250,000
Property, plant and equipment, net 3,420,410 1,359,280
Goodwill 16,383,069 16,383,069
Intangible assets, net 11,659,113 13,585,250
------------------ -----------------
Total non-current assets 32,962,592 33,577,599
------------------ -----------------
Total assets US$ 73,150,913 US$ 68,955,503
------------------ -----------------
Liabilities and shareholders' equity
Current liabilities:
Trade payables US$ 5,234,565 US$ 2,910,114
Accrued liabilities 7,727,924 6,680,989
Deferred revenue 1,342,797 344,719
Current portion of interest-bearing
loans and borrowings 2,217,473 1,015,471
------------------ -----------------
Total current liabilities 16,522,759 10,951,293
------------------ -----------------
Non-current liabilities:
Interest-bearing loans and borrowings 2,083,692 2,043,781
Deferred revenue 5,132,910 -
Other long term liabilities 133,266 -
------------------ -----------------
Total non-current liabilities 7,349,868 2,043,781
------------------ -----------------
50,716,173 50,644,949
106,655,281 106,212,297
17,631,722 12,932,003
(125,724,890) (113,828,820)
------------------ -----------------
Total shareholders' equity 49,278,286 55,960,429
------------------ -----------------
Total liabilities and shareholders'
equity US$ 73,150,913 US$ 68,955,503
IsoTis S.A.
Consolidated Statements of Cash Flows-Unaudited
US Dollars
Nine Months Ended
30-Sep-06 30-Sep-05
- -
Cash flows from operating activities
Net (loss) income from continuing
operations US$ (11,896,497)US$ 2,403,446
Adjustments to reconcile net (loss) income
to net cash used in operating activities:
Depreciation and amortization 2,516,901 2,405,608
Bad debt expense 213,709 141,535
Gain (loss) on sale of assets 17 (659,898)
Stock-based compensation expense 413,598 479,719
Foreign currency transaction (gain) loss 4,568,038 (8,625,190)
Change in operating assets and liabilities:
Inventories (2,863,302) (204,946)
Trade receivables (1,399,926) (1,895,226)
Other current assets 47,521 646,321
Deferred revenue (414,257) 136,910
Trade and other payables 2,854,413 (833,008)
Other long term liabilities 133,266 -
Restructuring provision - (673,197)
-------------- ------------
Net cash flows used in operating activities (5,826,519) (6,677,926)
Cash flows from investing activities
Purchase of property, plant and equipment (2,633,905) (439,516)
Proceeds from sale of dental assets 6,984,277
Proceeds from sale of property, plant and
equipment and assets 22,411 2,590,700
Change in restricted cash 1,378,164 1,381,372
-------------- ------------
Net cash flows provided by investing
activities 5,750,947 3,532,556
Cash flow from financing activities
Proceeds from issuance of common
shares 100,610 865,689
Proceeds from interest-bearing loans and
borrowings 2,000,000 -
Repayment of interest-bearing loans
and borrowings (762,090) (6,190,650)
-------------- ------------
Net cash flows provided by (used in)
financing activities 1,338,520 (5,324,961)
(Loss) on cash held in foreign currency (67,948) (30,701)
-------------- ------------
Net increase/(decrease) in cash and cash
equivalents 1,195,000 (8,501,032)
Cash and cash equivalents at the
beginning of the period 15,714,442 25,539,602
-------------- ------------
Cash and cash equivalents at the end of
the period US$ 16,909,442 US$ 17,038,570
For information contact: Hans Herklots, Director, Tel: +41-21-620-6011, E-mail: hans.herklots@isotis.com. IR Rob Morocco, CFO, +1-949-855-7155, robert.morocco@isotis.com